Precigen, Inc. (PGEN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Company Overview - Precigen Therapeutics is a biotech company focused on cell and gene therapy for various indications, including rare diseases and oncology [3] - The company is based in Maryland and aims to utilize differentiated technology and platforms tailored to specific indications with a clear regulatory strategy [3] Product Development - Precigen has successfully developed its first drug, PAPZIMEOS, which received approval in a rapid timeframe of four years from discovery to development [3]